cardiovascular outcomes glp-1 news today Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce risk Real-World Evidence for GLP-1 Receptor

Trump's weight loss drug announcement raises questions from the commercial market to Medicare.

Supresa Saffron Extract: Standardized to 0.3% safranal, this extract has been associated with a 69% decrease in hunger and a 55% reduction in snacking events over an eight-week period

Discover the evidence on GLP-1 receptor agonists in older adults, including safety considerations, side effects, dosing guidance, and monitoring requirements for elderly patients with diabetes.

Thirteen trials involving 5,807 participants were identified

GLP-1 receptor agonists (GLP-1 RAs) with exenatide b.i.d

Topics will include: Impact of biosimilars on the targeted immunomodulators (TIMs) category GLP-1 coverage strategies and their effects on plan design and member behavior New therapies and expanded indications in the dermatology landscape Dont miss this opportunity to gain valuable insights that can support smarter benefit decisions